{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:58:32Z","timestamp":1781650712023,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Myasthenia gravis (MG) is a chronic autoimmune disorder increasingly affecting older adults, with rising prevalence and comorbidity burden across Europe. Contemporary nationwide data describing MG-related hospital utilisation in European healthcare systems remain limited. We examined temporal trends and severity-related hospital outcomes in Spain between 2016 and 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective, population-based analysis using the Spanish Minimum Basic Data Set, including all adult hospital episodes with a primary diagnosis of MG (ICD-10-ES G70.00, G70.01). Hospital admissions, day-hospital visits and emergency department (ED) encounters were evaluated. Variables included demographics, intensive care unit (ICU) admission, myasthenic crisis, in-hospital mortality and comorbidities. Temporal trends were analysed using segmented negative binomial regression models incorporating a breakpoint in 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 20,251 MG-related episodes corresponding to 6,308 unique patients were identified. Following 2018, hospital admissions declined by 5.4% annually (95% CI\u2009\u2212\u20098.4 to \u2212\u20092.4), whereas day-hospital and ED utilisation increased markedly, particularly among older adults. In-hospital mortality remained low and stable (mean 2.6%). ICU admissions increased from 8.2% to 13.7% of hospitalised patients. Myasthenic crisis accounted for 4.5% of admissions and was strongly associated with ICU utilisation, representing 39% of all ICU stays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MG care in Spain is undergoing a sustained transition toward ambulatory management without evidence of worsening short-term hospital outcomes. Despite an ageing patient population and rising ICU utilisation, in-hospital mortality remained stable, supporting the safety of outpatient-based MG care models. These findings highlight the need for integrated clinical data to inform future healthcare planning in MG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42466-026-00485-5","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:37:31Z","timestamp":1776767851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in hospitalisation, myasthenic crisis and intensive care use in myasthenia gravis: a nationwide population-based study in Spain (2016\u20132022)"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4902-4755","authenticated-orcid":false,"given":"Tania","family":"Garrido-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5697-5980","authenticated-orcid":false,"given":"Javier","family":"Del-\u00c1guila-Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4510-0813","authenticated-orcid":false,"given":"Marta","family":"Rodr\u00edguez-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2109-1752","authenticated-orcid":false,"given":"Mar\u00eda del Mar","family":"Mart\u00ednez-Salmer\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5796-5872","authenticated-orcid":false,"given":"Beatriz","family":"V\u00e9lez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"4","key":"485_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/mus.27497","volume":"65","author":"O Gungor Tuncer","year":"2022","unstructured":"Gungor Tuncer, O., & Deymeer, F. (2022). Clinical course and outcome of an outpatient clinic population with myasthenia gravis and < scp>COVID -19. Muscle And Nerve, 65(4), 447\u2013452. https:\/\/doi.org\/10.1002\/mus.27497","journal-title":"Muscle And Nerve"},{"issue":"22","key":"485_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","volume":"94","author":"AC Guidon","year":"2020","unstructured":"Guidon, A. C., & Amato, A. A. (2020). COVID-19 and neuromuscular disorders. Neurology, 94(22), 959\u2013969. https:\/\/doi.org\/10.1212\/WNL.0000000000009566","journal-title":"Neurology"},{"key":"485_CR3","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s-Vicente, E., \u00c1lvarez-Velasco, R., Segovia, S., et al. (2020). Clinical and therapeutic features of myasthenia gravis in adults based on age at onset. Neurology, 94(11). https:\/\/doi.org\/10.1212\/WNL.0000000000008903","DOI":"10.1212\/WNL.0000000000008903"},{"issue":"1","key":"485_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr, A. S., Cardwell, C. R., McCarron, P. O., & McConville, J. (2010). A systematic review of population based epidemiological studies in Myasthenia Gravis. Bmc Neurology, 10(1), 46. https:\/\/doi.org\/10.1186\/1471-2377-10-46","journal-title":"Bmc Neurology"},{"issue":"1","key":"485_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1196\/annals.1254.053","volume":"998","author":"PHILLIPS LH","year":"2003","unstructured":"PHILLIPS LH. (2003). The Epidemiology of Myasthenia Gravis. Annals Of The New York Academy Of Sciences, 998(1), 407\u2013412. https:\/\/doi.org\/10.1196\/annals.1254.053","journal-title":"Annals Of The New York Academy Of Sciences"},{"issue":"1","key":"485_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.25122\/jml-2020-0145","volume":"14","author":"AM Bubuioc","year":"2021","unstructured":"Bubuioc, A. M., Kudebayeva, A., Turuspekova, S., Lisnic, V., & Leone, M. A. (2021). The epidemiology of myasthenia gravis. Journal Of Medicine And Life, 14(1), 7\u201316. https:\/\/doi.org\/10.25122\/jml-2020-0145","journal-title":"Journal Of Medicine And Life"},{"issue":"1","key":"485_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/jgs.12629","volume":"62","author":"J Aragon\u00e8s","year":"2014","unstructured":"Aragon\u00e8s, J., Roura-Poch, P., Hern\u00e1ndez\u2010Ocampo, E. M., et al. (2014). Myasthenia Gravis: A Disease of the Very Old. Journal Of The American Geriatrics Society, 62(1), 196\u2013197. https:\/\/doi.org\/10.1111\/jgs.12629","journal-title":"Journal Of The American Geriatrics Society"},{"key":"485_CR8","doi-asserted-by":"publisher","first-page":"116520","DOI":"10.1016\/j.jns.2019.116520","volume":"407","author":"JOT Sipil\u00e4","year":"2019","unstructured":"Sipil\u00e4, J. O. T., Soilu-H\u00e4nninen, M., Rautava, P., & Kyt\u00f6, V. (2019). Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004\u20132014: A retrospective national registry study. Journal Of The Neurological Sciences, 407, 116520. https:\/\/doi.org\/10.1016\/j.jns.2019.116520","journal-title":"Journal Of The Neurological Sciences"},{"key":"485_CR9","doi-asserted-by":"publisher","first-page":"jnnp","DOI":"10.1136\/jnnp-2023-333097","volume":"27","author":"J Vissing","year":"2024","unstructured":"Vissing, J., Atula, S., Savolainen, M., et al. (2024). Epidemiology of myasthenia gravis in Denmark, Finland and Sweden: a population-based observational study. J Neurol Neurosurg Psychiatry Published online March, 27, jnnp\u20132023. https:\/\/doi.org\/10.1136\/jnnp-2023-333097","journal-title":"J Neurol Neurosurg Psychiatry Published online March"},{"key":"485_CR10","doi-asserted-by":"publisher","unstructured":"Wartmann, H., Hoffmann, S., Ruck, T., Nelke, C., Deiters, B., Volmer, T., & Incidence (2023). Prevalence, hospitalization rates, and treatment patterns in myasthenia gravis: a 10-year real-world data analysis of German claims data. Neuroepidemiology, 57(2), 121\u2013128. https:\/\/doi.org\/10.1159\/000529583.","DOI":"10.1159\/000529583"},{"issue":"4","key":"485_CR11","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s13760-021-01662-w","volume":"121","author":"S \u017dupani\u0107","year":"2021","unstructured":"\u017dupani\u0107, S., Peri\u0107 \u0160itum, M., Majdak, M., Karaka\u0161, M., Ba\u0161i\u0107, S., & Spori\u0161, D. (2021). Case series of COVID-19 in patients with myasthenia gravis: a single institution experience. Acta Neurol Belg, 121(4), 1039\u20131044. https:\/\/doi.org\/10.1007\/s13760-021-01662-w","journal-title":"Acta Neurol Belg"},{"issue":"18","key":"485_CR12","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","volume":"72","author":"A Alshekhlee","year":"2009","unstructured":"Alshekhlee, A., Miles, J. D., Katirji, B., Preston, D. C., & Kaminski, H. J. (2009). Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology, 72(18), 1548\u20131554. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a41211","journal-title":"Neurology"},{"issue":"1","key":"485_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s41983-022-00516-3","volume":"58","author":"D Tugasworo","year":"2022","unstructured":"Tugasworo, D., Kurnianto, A., Retnaningsih, Andhitara, Y., Ardhini, R., & Budiman, J. (2022). The relationship between myasthenia gravis and COVID-19: a systematic review. Egypt J Neurol Psychiatr Neurosurg, 58(1), 83. https:\/\/doi.org\/10.1186\/s41983-022-00516-3","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"issue":"1","key":"485_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-022-11389-0","volume":"270","author":"F Stascheit","year":"2023","unstructured":"Stascheit, F., Grittner, U., Hoffmann, S., et al. (2023). Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis. Journal Of Neurology, 270(1), 1\u201312. https:\/\/doi.org\/10.1007\/s00415-022-11389-0","journal-title":"Journal Of Neurology"},{"key":"485_CR15","doi-asserted-by":"publisher","unstructured":"Kim, S., Lee, E. K., Kim, H., Kim, H., & Sohn, E. (2024). Impact of COVID-19 pandemic on the incidence and severity of myasthenia gravis in Korea: using National Health Insurance Service database. Frontiers In Neurology, 15. https:\/\/doi.org\/10.3389\/fneur.2024.1374370","DOI":"10.3389\/fneur.2024.1374370"},{"key":"485_CR16","unstructured":"Spain, R. (2015). Decree 69\/2015 (Real Decreto 69\/2015), of 6 February, Establishing the Specialized Health Care Activity Registry. BOE No 35, 10 February 2015. Ref: BOE-A-2015-1235.; https:\/\/www.boe.es\/boe\/dias\/2015\/02\/10\/pdfs\/BOE-A-2015-1235.pdf"},{"issue":"1","key":"485_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SMJ.0b013e31815d4398","volume":"101","author":"EM Bershad","year":"2008","unstructured":"Bershad, E. M., Feen, E. S., & Suarez, J. I. (2008). Myasthenia Gravis Crisis. Southern Medical Journal, 101(1), 63\u201369. https:\/\/doi.org\/10.1097\/SMJ.0b013e31815d4398","journal-title":"Southern Medical Journal"},{"key":"485_CR18","unstructured":"Spain National Institute of Statistics (INE). https:\/\/www.ine.es\/en\/"},{"key":"485_CR19","doi-asserted-by":"publisher","unstructured":"Habib, A. A., Sacks, N., Cool, C., et al. (2024). Hospitalizations and Mortality From Myasthenia Gravis. Neurology, 102(2). https:\/\/doi.org\/10.1212\/WNL.0000000000207863","DOI":"10.1212\/WNL.0000000000207863"},{"issue":"Suppl. 1","key":"485_CR20","first-page":"S17","volume":"60","author":"A Habib","year":"2019","unstructured":"Habib, A., Korb, M., Goyal, N., & Mozaffar, T. (2019). Trends in hospital admissions for myasthenia gravis with acute exacerbations. Muscle And Nerve, 60(Suppl. 1), S17.","journal-title":"Muscle And Nerve"},{"issue":"5","key":"485_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1159\/000539577","volume":"59","author":"F Sciancalepore","year":"2024","unstructured":"Sciancalepore, F., Lombardi, N., Valdiserra, G., et al. (2024). Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic Review. Neuroepidemiology, 59(5), 579\u2013592. https:\/\/doi.org\/10.1159\/000539577","journal-title":"Neuroepidemiology"},{"issue":"2","key":"485_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.5005\/jp-journals-10071-23930","volume":"26","author":"S Singh","year":"2022","unstructured":"Singh, S., Taank, P., Vashishtha, P., Gupta, N., & Wadke, R. (2022). Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links. Indian Journal of Critical Care Medicine, 26(2), 248\u2013249. https:\/\/doi.org\/10.5005\/jp-journals-10071-23930","journal-title":"Indian Journal of Critical Care Medicine"},{"key":"485_CR23","doi-asserted-by":"publisher","first-page":"106834","DOI":"10.1016\/j.clineuro.2021.106834","volume":"208","author":"N Karimi","year":"2021","unstructured":"Karimi, N., Okhovat, A. A., Ziaadini, B., Haghi Ashtiani, B., Nafissi, S., & Fatehi, F. (2021). Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases. Clinical Neurology And Neurosurgery, 208, 106834. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106834","journal-title":"Clinical Neurology And Neurosurgery"},{"issue":"12","key":"485_CR24","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.7326\/L20-0845","volume":"173","author":"DA Restivo","year":"2020","unstructured":"Restivo, D. A., Centonze, D., Alesina, A., & Marchese-Ragona, R. (2020). Myasthenia Gravis Associated With SARS-CoV-2 Infection. Annals Of Internal Medicine, 173(12), 1027\u20131028. https:\/\/doi.org\/10.7326\/L20-0845","journal-title":"Annals Of Internal Medicine"},{"key":"485_CR25","doi-asserted-by":"publisher","first-page":"106488","DOI":"10.1016\/j.clineuro.2021.106488","volume":"202","author":"J Kalita","year":"2021","unstructured":"Kalita, J., Tripathi, A., Dongre, N., & Misra, U. K. (2021). Impact of COVID-19 pandemic and lockdown in a cohort of myasthenia gravis patients in India. Clinical Neurology And Neurosurgery, 202, 106488. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106488","journal-title":"Clinical Neurology And Neurosurgery"},{"key":"485_CR26","doi-asserted-by":"publisher","unstructured":"Sol\u00e9, G., Mathis, S., Friedman, D., et al. (2021). Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis. Neurology, 96(16). https:\/\/doi.org\/10.1212\/WNL.0000000000011669","DOI":"10.1212\/WNL.0000000000011669"},{"issue":"02","key":"485_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.32598\/bcn.2023.4360.5","volume":"15","author":"A Nafari","year":"2024","unstructured":"Nafari, A., Shojaei, S., Khoshnood, R. J., et al. (2024). Myasthenia Gravis and COVID-19: A Systematic Review and Meta-analysis. Basic and Clinical Neuroscience Journal, 15(02), 175\u2013184. https:\/\/doi.org\/10.32598\/bcn.2023.4360.5","journal-title":"Basic and Clinical Neuroscience Journal"},{"issue":"9\u201310","key":"485_CR28","first-page":"453","volume":"134","author":"T Pekmezovi\u0107","year":"2006","unstructured":"Pekmezovi\u0107, T., Lavrni\u0107, D., Jarebinski, M., & Apostolski, S. (2006). [Epidemiology of myasthenia gravis]. Srpski Arhiv Za Celokupno Lekarstvo, 134(9\u201310), 453\u2013456.","journal-title":"Srpski Arhiv Za Celokupno Lekarstvo"},{"issue":"1","key":"485_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1196\/annals.1405.040","volume":"1132","author":"JA Aarli","year":"2008","unstructured":"Aarli, J. A. (2008). Myasthenia Gravis in the Elderly. Annals Of The New York Academy Of Sciences, 1132(1), 238\u2013243. https:\/\/doi.org\/10.1196\/annals.1405.040","journal-title":"Annals Of The New York Academy Of Sciences"},{"issue":"8","key":"485_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/jnnp.74.8.1105","volume":"74","author":"A Vincent","year":"2003","unstructured":"Vincent, A. (2003). Evidence of underdiagnosis of myasthenia gravis in older people. Journal Of Neurology, Neurosurgery And Psychiatry, 74(8), 1105\u20131108. https:\/\/doi.org\/10.1136\/jnnp.74.8.1105","journal-title":"Journal Of Neurology, Neurosurgery And Psychiatry"},{"key":"485_CR31","doi-asserted-by":"publisher","unstructured":"Hernandez Fustes, O. J., Arteaga Rodriguez, C., & Hernandez Fustes, O. J. (2020). Myasthenia Gravis with Elderly Onset at Advanced Age. Cureus Published online January, 29. https:\/\/doi.org\/10.7759\/cureus.6808","DOI":"10.7759\/cureus.6808"},{"key":"485_CR32","doi-asserted-by":"publisher","unstructured":"Myllynen, C., Tuulasvaara, A., Atula, S., & Laakso, S. M. (2024). Intensive care due to myasthenia gravis: Risk factors and prognosis. European Journal Of Neurology, 31(12). https:\/\/doi.org\/10.1111\/ene.16522","DOI":"10.1111\/ene.16522"},{"key":"485_CR33","doi-asserted-by":"publisher","unstructured":"Neumann, B., Angstwurm, K., Mergenthaler, P., et al. (2020). Myasthenic crisis demanding mechanical ventilation. Neurology, 94(3). https:\/\/doi.org\/10.1212\/WNL.0000000000008688","DOI":"10.1212\/WNL.0000000000008688"},{"key":"485_CR34","doi-asserted-by":"publisher","first-page":"100063","DOI":"10.1016\/j.lanwpc.2020.100063","volume":"5","author":"J Chen","year":"2020","unstructured":"Chen, J., Tian, D. C., Zhang, C., et al. (2020). Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study. Lancet Reg Health West Pac, 5, 100063. https:\/\/doi.org\/10.1016\/j.lanwpc.2020.100063","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"485_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12883-022-02692-4","volume":"22","author":"L Harris","year":"2022","unstructured":"Harris, L., Graham, S., MacLachlan, S., Exuzides, A., & Jacob, S. (2022). A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis. Bmc Neurology, 22(1), 172. https:\/\/doi.org\/10.1186\/s12883-022-02692-4","journal-title":"Bmc Neurology"},{"issue":"6","key":"485_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1159\/000478012","volume":"63","author":"A Watad","year":"2017","unstructured":"Watad, A., Bragazzi, N. L., Adawi, M., et al. (2017). Autoimmunity in the Elderly: Insights from Basic Science and Clinics - A Mini-Review. Gerontology, 63(6), 515\u2013523. https:\/\/doi.org\/10.1159\/000478012","journal-title":"Gerontology"},{"issue":"10","key":"485_CR37","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00018-012-0970-0","volume":"69","author":"JJ Goronzy","year":"2012","unstructured":"Goronzy, J. J., & Weyand, C. M. (2012). Immune aging and autoimmunity. Cellular and Molecular Life Sciences, 69(10), 1615\u20131623. https:\/\/doi.org\/10.1007\/s00018-012-0970-0","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"3","key":"485_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0022-510X(83)90095-3","volume":"58","author":"PC Limburg","year":"1983","unstructured":"Limburg, P. C., The, T. H., Hummel-Tappel, E., & Oosterhuis, H. J. G. H. (1983). Anti-acetylcholine receptor antibodies in myasthenia gravis. Journal Of The Neurological Sciences, 58(3), 357\u2013370. https:\/\/doi.org\/10.1016\/0022-510X(83)90095-3","journal-title":"Journal Of The Neurological Sciences"},{"issue":"5","key":"485_CR39","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1212\/WNL.40.5.786","volume":"40","author":"DH Donaldson","year":"1990","unstructured":"Donaldson, D. H., Ansher, M., Horan, S., Rutherford, R. B., & Ringel, S. P. (1990). The relationship of age to outcome in myasthenia gravis. Neurology, 40(5), 786\u2013786. https:\/\/doi.org\/10.1212\/WNL.40.5.786","journal-title":"Neurology"},{"issue":"2","key":"485_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.nrleng.2020.06.013","volume":"38","author":"DA Garc\u00eda Est\u00e9vez","year":"2023","unstructured":"Garc\u00eda Est\u00e9vez, D. A., L\u00f3pez D\u00edaz, L. M., Pardo Parrado, M., et al. (2023). Epidemiology of myasthenia gravis in the province of Ourense (Galicia, Spain). Neurolog\u00eda (English Edition), 38(2), 75\u201381. https:\/\/doi.org\/10.1016\/j.nrleng.2020.06.013","journal-title":"Neurolog\u00eda (English Edition)"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00485-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-026-00485-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00485-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:29:08Z","timestamp":1781648948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42466-026-00485-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1186\/s42466-026-00485-5","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and its later amendments. The study protocol was reviewed and approved by the Almeria Provincial Research Ethics Committee (Ethics Committee of Almeria; approval number 61\/2025).The data were obtained from the Spanish National Hospital Discharge Database (Conjunto M\u00ednimo B\u00e1sico de Datos, CMBD), provided by the Spanish Ministry of Health following formal request and approval. All data were fully anonymised at the source and contained no direct or indirect personal identifiers. In accordance with national legislation, informed consent was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BVG has received research funding from ArgenX and honoraria for lectures or advisory activities from Alnylam, Biogen, Roche, ArgenX, UCB and Alexion. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}